Gram-negative blood-stream infections and emerging antimicrobial resistance in children with acute myeloid leukemia during induction chemotherapy at Children’s Cancer Hospital Egypt 57357
Authors:
Open Access
- 22 April 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1540831
Abstract
Background: In children receiving therapy for acute myeloid leukemia (AML), gram-negative bacteremia is associated with significant morbidity and mortality, especially in the presence of multi-drug resistant [MDR] organisms. objectives: The purpose of this study was to determine the prevalence and antibiotic susceptibility patterns of gram negativebloodstream infections [GNBSI]] during the period of induction chemotherapy [IC] and the associated morbidity and mortality in a large pediatric oncology hospital in a low- middle-income country (LMIC). patients and methods: This is a retrospective analysis of consecutive newly diagnosed patients with acute myeloid leukemia (AML) admitted for induction chemotherapy (IC) from January 2015 to December 2017 at the Children’s Cancer Hospital Egypt 57357. Results: We identified 90[27.4%] children with at least one GNBSI during induction, 72/90[80%] of whom had at least one MDR GNBSI. 124 GNBSI episodes were identified among the ninety children: E.coli 54.8%, K.pneumoniae 16.9%, A.baumannii 6.5%, E.cloacae 4.8%, and P.aeruginosa 4.0%. Thirty-day cumulative infection-related mortality was 27.8% [18.9-37.3%]. Associated morbidity included typhlitis [29/90 (32.2%)], sepsis-related central venous catheter [CVC] removal [12/90 (13.3%)], and admission to intensive care unit [38/90(42%)]. Conclusion: Our study highlights the prevalence of gram-negative bacteria among febrile neutropenic children with AML and the high incidence of antibiotic resistance in our hospital. There is a need for keen surveillance globally of the epidemiology of multi-drug resistant gram-negative organisms and thoughtful studies into antibiotic stewardship to reduce the growing threat of MDR GN infections and the associated morbidity and mortality.Keywords
This publication has 42 references indexed in Scilit:
- SIOP PODC adapted risk stratification and treatment guidelines: Recommendations for acute myeloid leukemia in resource‐limited settingsPediatric Blood & Cancer, 2019
- Associations between neutrophil recovery time, infections and relapse in pediatric acute myeloid leukemiaPediatric Blood & Cancer, 2018
- Combating blood stream infections during induction chemotherapy in children with acute myeloid leukemia: Single center results in IndiaPediatric Blood & Cancer, 2017
- Association between prolonged neutropenia and reduced relapse risk in pediatric AML: A report from the children's oncology groupInternational Journal of Cancer, 2016
- Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patientsJournal of Infection, 2014
- A scoring system to predict the risk of death during induction with anthracycline plus cytarabine‐based chemotherapy in patients with de novo acute myeloid leukemiaCancer, 2011
- Antibiotic resistance is associated with longer bacteremic episodes and worse outcome in febrile neutropenic children with cancerPediatric Blood & Cancer, 2010
- Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trialThe Lancet Oncology, 2010
- The threat of antibiotic resistance in Gram-negative pathogenic bacteria: β-lactams in peril!Current Opinion in Microbiology, 2005
- Chemotherapy‐induced neutropeniaCancer, 2004